Micrograph of malignant mesothelioma. Credit: Nephron/ commons.wikimedia.org. Avenge Bio has obtained orphan drug designation from the US Food and Drug Administration (FDA) for its AVB-001
Flamingo will use the grant to support translational research in its lead clinical programme, danvatirsen. Credit: Michal Jarmoluk from Pixabay. Flamingo Therapeutics has received a
The Abu Dhabi DoH has entered a declaration of collaboration with Mass General Brigham’s International Center for Genetic Disease. Credit: Department of Health Abu Dhabi.
With the addition of start-up.ai’s capabilities, Verix can continue its growth by advancing its AI platform. Credit: LeoWolfert / shutterstock.com. Artificial intelligence (AI)-driven commercial optimisation
Genentech’s Columvi will become available in the US in summer 2023. Credit: Coolcaesar / commons.wikimedia.org. Roche Group member Genentech has secured approval from the US
Soligenix has the right to purchase the topical formulation. Credit: AdoreBeautyNZ from Pixabay. Soligenix has signed an exclusive option agreement with Silk Road Therapeutics for
Marker’s T cell therapy has shown potential in identifying and killing cancer cells. Credit: NICHD/J. Lippincott-Schwartz / Flickr (Creative Commons). Marker Therapeutics has reached a
ERAS-801 is intended to treat patients with glioblastoma. Credit: Mikael Häggström, M.D./ commons.wikimedia.org. Erasca has received the US Food and Drug Administration’s (FDA) fast track